• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

IDBI Bank Ltd
Industry :  Banks - Private Sector
BSE Code
ISIN Demat
Book Value()
500116
INE008A01015
55.4493897
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IDBI
9.4
90438.45
EPS(TTM)
Face Value()
Div & Yield %
8.95
10
0
 

balaxi pharmaceuticals ltd
Khoobsurat reports standalone net loss of Rs 4.70 crore in the March 2026 quarter
Jun 01,2026
Net Loss of Khoobsurat reported to Rs 4.70 crore in the quarter ended March 2026 as against net loss of Rs 0.60 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.47 crore in the year ended March 2026 as against net loss of Rs 2.22 crore during the previous year ended March 2025. Sales reported to Rs 0.34 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.